Joel Morse is Founder and CEO of Curavit, a virtual contract research organization (VCRO) that designs and executes decentralized clinical trials. Previously, Morse founded C3i, a Business Process Outsourcing (BPO) healthcare provider, and built it into a global leader in tech-enabled clinical trial services, with a strategic client list that included Medidata, Quintiles, and Merck.